Literature DB >> 20130221

HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications.

Victor G Valcour1, Bruce T Shiramizu, Cecilia M Shikuma.   

Abstract

It is broadly accepted that HIV DNA in lymphoid and myeloid cells persists despite combination antiretroviral therapy. Recognized as the Achilles heel to HIV eradication, the role of these peripheral reservoirs in HIV morbidity is less well developed. The burden of HIV DNA in peripheral mononuclear cells is linked to HIV disease outcomes such as time to AIDS diagnosis, survival, and CD4 T-lymphocyte counts. Monocytes are a minor HIV DNA reservoir, and the burden of HIV DNA in these cells appears to be linked to dementia, suggesting that residual infection in this subset is linked to tissue-related HIV complications. Since monocytes are likely involved in trafficking virus to the brain, there is a strong mechanistic link underlying this discovery. Herein, we summarize our current understanding of monocyte HIV DNA and central nervous system dysfunction in humans. We present a model to understand these relationships and suggest possible treatment approaches to be tested.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130221      PMCID: PMC2858306          DOI: 10.1189/jlb.0809571

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  66 in total

1.  Monokine products as predictors of AIDS dementia.

Authors:  L Pulliam; J A Clarke; M S McGrath; D Moore; D McGuire
Journal:  AIDS       Date:  1996-11       Impact factor: 4.177

2.  Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy.

Authors:  Francesca Vitone; Davide Gibellini; Pasqua Schiavone; Maria Carla Re
Journal:  J Clin Virol       Date:  2004-12-15       Impact factor: 3.168

3.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

Review 4.  Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies.

Authors:  Stefano Aquaro; Valentina Svicher; Dominique Schols; Michela Pollicita; Andrea Antinori; Jan Balzarini; Carlo Federico Perno
Journal:  J Leukoc Biol       Date:  2006-08-24       Impact factor: 4.962

5.  Level of human immunodeficiency virus DNA in peripheral blood mononuclear cells correlates with efficacy of antiretroviral therapy.

Authors:  J L McDermott; A A Giri; I Martini; M Bono; M Giacomini; A Campelli; L Tagliaferro; A Cara; O E Varnier
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

Review 6.  Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

Authors:  Morris Schambelan; Constance A Benson; Andrew Carr; Judith S Currier; Michael P Dubé; John G Gerber; Steven K Grinspoon; Carl Grunfeld; Donald P Kotler; Kathleen Mulligan; William G Powderly; Michael S Saag
Journal:  J Acquir Immune Defic Syndr       Date:  2002-11-01       Impact factor: 3.731

7.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

Review 8.  Latency: the hidden HIV-1 challenge.

Authors:  Alessandro Marcello
Journal:  Retrovirology       Date:  2006-01-16       Impact factor: 4.602

9.  HIV and cardiovascular disease: contribution of HIV-infected macrophages to development of atherosclerosis.

Authors:  Michael Bukrinsky; Dmitri Sviridov
Journal:  PLoS Med       Date:  2007-01       Impact factor: 11.069

10.  Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy.

Authors:  Pauline Chugh; Birgit Bradel-Tretheway; Carlos M R Monteiro-Filho; Vicente Planelles; Sanjay B Maggirwar; Stephen Dewhurst; Baek Kim
Journal:  Retrovirology       Date:  2008-01-31       Impact factor: 4.602

View more
  50 in total

1.  Dopamine receptor D3 genetic polymorphism (rs6280TC) is associated with rates of cognitive impairment in methamphetamine-dependent men with HIV: preliminary findings.

Authors:  Saurabh Gupta; Chad A Bousman; Gursharan Chana; Mariana Cherner; Robert K Heaton; Reena Deutsch; Ronald J Ellis; Igor Grant; Ian P Everall
Journal:  J Neurovirol       Date:  2011-04-14       Impact factor: 2.643

2.  Regional cortical thinning associated with detectable levels of HIV DNA.

Authors:  Kalpana J Kallianpur; Gregory R Kirk; Napapon Sailasuta; Victor Valcour; Bruce Shiramizu; Beau K Nakamoto; Cecilia Shikuma
Journal:  Cereb Cortex       Date:  2011-10-19       Impact factor: 5.357

Review 3.  Impact of Myeloid Reservoirs in HIV Cure Trials.

Authors:  Brooks I Mitchell; Elizabeth I Laws; Lishomwa C Ndhlovu
Journal:  Curr HIV/AIDS Rep       Date:  2019-04       Impact factor: 5.071

4.  Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders.

Authors:  Yisel Cantres-Rosario; Marines Plaud-Valentín; Yamil Gerena; Richard L Skolasky; Valerie Wojna; Loyda M Meléndez
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

5.  Peripheral blood HIV DNA is associated with atrophy of cerebellar and subcortical gray matter.

Authors:  Kalpana J Kallianpur; Cecilia Shikuma; Gregory R Kirk; Bruce Shiramizu; Victor Valcour; Dominic Chow; Scott Souza; Beau Nakamoto; Napapon Sailasuta
Journal:  Neurology       Date:  2013-04-17       Impact factor: 9.910

Review 6.  Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.

Authors:  Véronique Avettand-Fènoël; Laurent Hocqueloux; Jade Ghosn; Antoine Cheret; Pierre Frange; Adeline Melard; Jean-Paul Viard; Christine Rouzioux
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

Review 7.  The three human monocyte subsets: implications for health and disease.

Authors:  Kok Loon Wong; Wei Hseun Yeap; June Jing Yi Tai; Siew Min Ong; Truong Minh Dang; Siew Cheng Wong
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

8.  Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy.

Authors:  B Shiramizu; J Ananworanich; T Chalermchai; U Siangphoe; D Troelstrup; C Shikuma; V De Grutolla; P Sithinamsuwan; P Praihirunkit; S Rattanamanee; V Valcour
Journal:  J Neurovirol       Date:  2011-12-30       Impact factor: 2.643

Review 9.  Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy.

Authors:  Ramona Bhatia; Patrick Ryscavage; Babafemi Taiwo
Journal:  J Neurovirol       Date:  2011-12-29       Impact factor: 2.643

Review 10.  Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.

Authors:  Peter J Gaskill; Tina M Calderon; Jacqueline S Coley; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-01       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.